# Checkmate Pharmaceuticals funding: rounds and investors

> Checkmate Pharmaceuticals has raised $69M across 3 rounds since 2015. Investors include venBio Partners, F-Prime Capital and Sofinnova Investments.

Source: https://millionrounds.com/company/checkmate-pharmaceuticals (Millionrounds; every figure on the page links to its filing or article)

United States · [Funded startup](https://millionrounds.com/companies)

# Who invested in *Checkmate Pharmaceuticals*

3 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech Healthcare

Funding summary Updated 26 Oct 2026

**$69M** raised across 3 rounds since 2015, from 3 sources

**$20M** Series A **$27M** Series B **$22M** Round

- **Latest round:** Round, $22M Dec 2018
- **Biggest round:** $27M Series B · Jun 2017
- **Investors:** 5

See who backed them

## The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2016 2017 2018

**$20M** Series A

**$27M** Series B

**$22M** Round

- **First round:** Series A, $20M
- **Biggest round:** $27M
- **Usual gap between rounds:** 22 months

## The rounds

- **Dec 2018** Round **$22M** *2 new* *1 returning* [F-Prime Capital](https://millionrounds.com/fund/f-prime) [venBio Partners](https://millionrounds.com/fund/venbio) Decheng Capital/ Sofinnova Reported by FinSMEs SEC filing: $11M sold, first sale Nov 2018
- **Jun 2017** Series B **$27M** *1 new* *1 returning* [venBio Partners](https://millionrounds.com/fund/venbio) F-Prime Capital Partners/ Sofinnova Reported by FinSMEs SEC filing: $27M sold, first sale Jun 2017
- **Aug 2015** Series A **$20M** *2 new* [Sofinnova Investments](https://millionrounds.com/fund/sofinnova-investments) [venBio Partners](https://millionrounds.com/fund/venbio) From a historical funding record SEC filing: $10M sold, first sale Aug 2015

## Founders and team

From the SEC filings it signed: 7 on the team.

- **Arthur Krieg** Executive Officer, Director i
- **Barry Labinger** Executive Officer, Director i
- **Charles Yon** Executive Officer i
- **James Wooldridge** Executive Officer i
- **Jonathan Lieber** Executive Officer i
- **Karen Brennan** Executive Officer i
- **Kleem Chaudhary** Executive Officer i

On the board, as filed i *Alan Fuhrman* *Corey Goodman* *Keith Flaherty* *Michael Powell* *Peter Colabuono* *Robert Weisskoff*

## Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

**Series A** 2015 **Series B** 2017 **Round** 2018 [venBio Partners](https://millionrounds.com/fund/venbio) [F-Prime Capital](https://millionrounds.com/fund/f-prime) [Sofinnova Investments](https://millionrounds.com/fund/sofinnova-investments) Decheng Capital/ Sofinnova F-Prime Capital Partners/ Sofinnova

## Everyone who backed them

[venBio Partners](https://millionrounds.com/fund/venbio) VC firm **3** rounds

[F-Prime Capital](https://millionrounds.com/fund/f-prime) VC firm **1** round

[Sofinnova Investments](https://millionrounds.com/fund/sofinnova-investments) VC firm **1** round

Decheng Capital/ Sofinnova no record of our own yet **1** round

F-Prime Capital Partners/ Sofinnova no record of our own yet **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=checkmate-pharmaceuticals).

## Also claim to have backed them

This firm lists Checkmate Pharmaceuticals as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

[Longitude Capital](https://millionrounds.com/fund/longitude-capital) VC firm Per its own site

## Quick answers about Checkmate Pharmaceuticals

### Who invested in Checkmate Pharmaceuticals?

Checkmate Pharmaceuticals's investors include venBio Partners, F-Prime Capital, Sofinnova Investments, Decheng Capital/ Sofinnova and F-Prime Capital Partners/ Sofinnova.

### How much has Checkmate Pharmaceuticals raised?

Checkmate Pharmaceuticals has raised $69M across 3 rounds since 2015.

### When did Checkmate Pharmaceuticals last raise?

Checkmate Pharmaceuticals's most recent round was an Undisclosed round of $22M in Dec 2018.

### What was Checkmate Pharmaceuticals's biggest round?

Checkmate Pharmaceuticals's largest round on record is $27M (Series B), in Jun 2017.

### Who backed Checkmate Pharmaceuticals first?

Checkmate Pharmaceuticals's first round on record, in Aug 2015, was backed by Sofinnova Investments and venBio Partners.

### What stage is Checkmate Pharmaceuticals at?

Checkmate Pharmaceuticals's latest named round is an Undisclosed round, in Dec 2018.

### Where is Checkmate Pharmaceuticals based?

Checkmate Pharmaceuticals is based in the United States.

## Companies like Checkmate Pharmaceuticals

In the same sector, and raised in the last eighteen months.

[**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**Prolific Machines** $105M · Oct 2026](https://millionrounds.com/company/prolific-machines)[**AI** $18M · Oct 2026](https://millionrounds.com/company/ai)[**Baba** $40M · Oct 2026](https://millionrounds.com/company/baba)[**IMIO** $19M · Oct 2026](https://millionrounds.com/company/imio)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app
